Photo Gallery

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from  7.454 to 7.632  due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • WJPPS NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2020 Issue has been successfully launched on 1 November 2020

Abstract

ESTIMATION OF FLUTICASONE PROPIONATE IN NASAL PREPARATION AND IN COMBINATION WITH FORMOTEROL FUMARATE IN INHALATION PREPARATION

Priyank P. Raval*, Dr. J. B. Dave , Mittal P. Joshi, and Bhargav K. Solanki

ABSTRACT

The Reversed Phase Ion Pair HPLC method has been developed and validated for the estimation of Fluticasone propionate in nasal preparation and in combination with Formoterol fumarate in DPI (Dry Powder Inhalation). This method was developed using ACE C18 Column (150 mm×4.6 mm id, 5μm) and Acetonitrile: 10mM Sodium di-hydrogen ortho phosphate buffer containing 10 mM Decane sulphonic acid sodium salt (50:50 v/v) as the mobile phase at 1ml/min flow rate with detection at 220nm.Decane sulphonic acid sodium salt proved to be better than other anionic ion pairing agents. This method was validated as per ICH guideline. The method was linear in the concentration of 1.5-12 μg/mL for Formoterol and 25-200 μg/mL for Fluticasone with a correlation coefficient of 0.999 each. The LOQ for Formoterol and Fluticasone was 0.0244μg/ml and 0.7445μg/ml respectively. The method successfully separated both the drugs from potential degradation products in stress samples with adequate peak purity establishing specificity and stability indicating nature of the method. Both the drugs degraded under photolytic condition; but Fluticasone degraded more and yielded there degradation peaks which further increased in presence of Formoterol. Both the drugs did not show degradation under thermal, thermal-humidity conditions. Fluticasone was more susceptible to alkaline hydrolysis giving two degradation peaks as compared to acidic hydrolysis when yielded one degradation peak. All method validation parameters were within the acceptance criteria as per ICH guideline. The method is deemed to be stability indicating as it separates both the drugs from likely degradation products.

Keywords: Formoterol fumarate, Fluticasone propionate, Dry Powder Inhalation, Nasal spray, Forced degradation study


[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More